L-648,051: an aerosol active leukotriene D4 receptor antagonist.
Jones
T R
TR
Department of Pharmacology and Medicinal Chemistry, Merck Frosst Canada Inc., Pointe Claire-Dorval, Québec.
Guindon
Y
Y
Champion
E
E
Charette
L
L
DeHaven
R N
RN
Denis
D
D
Ethier
D
D
Ford-Hutchinson
A W
AW
Fortin
R
R
Frenette
R
R
D000336:Aerosols; D000818:Animals; D000941:Antigens / Q000276:immunology; D001980:Bronchi / Q000187:drug effects; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007651:Keto Acids; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010654:Phenylbutyrates / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin / Q000187:drug effects* / Q000378:metabolism; D012453:Saimiri; D013450:Sulfones; D014132:Trachea / Q000187:drug effects / Q000276:immunology
D000336:Aerosols; D000941:Antigens; D007651:Keto Acids; D010654:Phenylbutyrates; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin; D013450:Sulfones; C052024:L 648051